Wearable Graphene-based smart face mask for Real-Time human respiration monitoring.

After the pandemic of SARS-CoV-2, the use of face-masks is considered the most effective way to prevent the spread of virus-containing respiratory fluid. As the virus targets the lungs directly, causing shortness of breath, continuous respiratory monitoring is crucial for evaluating health status. Therefore, the need for a smart face mask (SFM) capable of wirelessly monitoring human respiration in real-time has gained enormous attention. However, some challenges in developing these devices should be solved to make practical use of them possible. One key issue is to design a wearable SFM that is biocompatible and has fast responsivity for non-invasive and real-time tracking of respiration signals. Herein, we present a cost-effective and straightforward solution to produce innovative SFMs by depositing graphene-based coatings over commercial surgical masks. In particular, graphene nanoplatelets (GNPs) are integrated into a polycaprolactone (PCL) polymeric matrix. The resulting SFMs are characterized morphologically, and their electrical, electromechanical, and sensing properties are fully assessed. The proposed SFM exhibits remarkable durability (greater than1000 cycles) and excellent fast response time (∼42 ms), providing simultaneously normal and abnormal breath signals with clear differentiation. Finally, a developed mobile application monitors the mask wearer's breathing pattern wirelessly and provides alerts without compromising user-friendliness and comfort.

Novel mutations responsible for α-thalassemia in Iranian families.

α-Thalassemia (α-thal) is usually caused by deletions on the α-globin gene cluster and the role of point mutations is less well investigated. In the present study, a total of 1048 individuals with hypochromic microcytic anemia, who did not present the most common α-thal deletions, were referred for α-globin gene DNA sequencing. The nucleotide changes were studied and a total of five new mutations was identified, of which three were located on the α2 gene [codon7 (Lys→Stop), codon 34 (Leu→Pro) and codon 83 (Leu→Arg)] and two on the α1 gene [IVS-I-116 (A>G) and codon 44 (+C)]. These novel mutations not only explain new findings by molecular analysis of the α-globin gene but also have clinical importance due to their changes in α-globin production in means of decreased hemoglobin (Hb) related values. Moreover, considerations of its role in combination with other mutations, and the possibility of causing Hb H (ß4) are yet to be studied.